Involvement of in the abnormal hyperphosphorylation of tau and its reversal by Memantine
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The activity of protein phosphatase (PP)‐2A, which regulates tau phosphorylation, is compromised in Alzheimer disease brain. Here we show that the transient transfection of PC12 cells with inhibitor‐2 of PP2A causes abnormal hyperphosphorylation of tau at Ser396/Ser404 and Ser262/Ser356. This hyperphosphorylation of tau is observed only when a sub‐cellular shift of takes place from the nucleus to the cytoplasm and is accompanied by cleavage of into a 20 kDa fragment. Memantine, an un‐competitive inhibitor of N‐methyl‐d‐aspartate receptors, inhibits this abnormal phosphorylation of tau and cell death and prevents the inhibition of PP2A activity in vitro. These findings demonstrate novel mechanisms by which regulates the intracellular activity of PP2A and phosphorylation of tau, and by which Memantine modulates PP2A signaling and inhibits neurofibrillary degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Self-citationMemantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909 · cited 15×
“It is this excessive opening of the NMDAR channels which allows Memantine to gain access to the internal Mg2+ binding site.”
BackgroundResultInfluentialPhosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Self-citationUp-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s disease
Tanimukai, H., Grundke-Iqbal, I., & Iqbal, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62486-8 · Cited by 220
Self-citationSun, L., Liu, S. Y., Zhou, X. W., Wang, X. C., Liu, R., Wang, Q., & Wang, J. Z. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00697-8 · Cited by 168
Kins, S., Kurosinski, P., Nitsch, R. M., & Götz, J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63444-x · Cited by 155 · cited 1×
“directly by dephosphorylation of tau but also by regulating the activities of several tau kinases [16,24–26].”
BackgroundTsujio, I., Zaidi, T., Xu, J., Kotula, L., Grundke-Iqbal, I., & Iqbal, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.097 · Cited by 80
Self-citation
Research works printed but not linked: 23
- 10.1074/jbc.275.8.5535 · DOI · Paper page
- 10.1021/bi00006a020 · DOI · Paper page
- 10.1021/bi960581y · DOI · Paper page
- 10.1128/MCB.12.8.3346 · DOI · Paper page
- 10.1074/jbc.271.19.11059 · DOI · Paper page
- 10.1515/bchm3.1994.375.2.113 · DOI · Paper page
- 10.1046/j.1365-2443.1996.d01-223.x · DOI
- 10.1006/bbrc.1999.0790 · DOI
- 10.1006/excr.1997.3930 · DOI
- 10.1523/JNEUROSCI.21-20-07985.2001 · DOI · Paper page
- 10.1016/j.febslet.2004.04.047 · DOI · Paper page
- Li Y.F., 2003, Inhibition of N-methyl-d-aspartate receptor function appears to be one of the common actions for antidepressants, J. Psychopharmacol.
- 10.1113/jphysiol.1996.sp021153 · DOI
- 10.1111/j.1471-4159.2004.02147.x · DOI · Paper page
- 10.1074/jbc.273.51.34511 · DOI · Paper page
- 10.1074/jbc.270.16.9645 · DOI
- 10.1073/pnas.92.10.4279 · DOI · Paper page
- 10.1016/S0014-5793(01)02127-5 · DOI · Paper page
- 10.1016/S0002-9440(10)63445-1 · DOI
- 10.1042/bj3410293 · doi:10.1042/bj3410293 · Paper page
- 10.1186/gb-2001-2-6-reviews3008 · DOI
- 10.1124/jpet.105.085142 · DOI
- 10.1038/jcbfm.1991.65 · DOI · Paper page
Cited by
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
Self-citationMechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Self-citationThe Role of Tau in Alzheimer's Disease and Related Disorders
Medeiros, R., Baglietto‐Vargas, D., & LaFerla, F. M. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00177.x · Cited by 432
Metadata
- Authors
- Chohan, M. O., Khatoon, S., Iqbal, I.-G., & Iqbal, K.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2006-06-19
- Volume
- 580
- Issue
- 16
- Pages
- 3973-3979
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2032566236
- Cited by
- 119
- References
- 8
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.